Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Income from Continuing Operations readings, the most recent being 2085669.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 8.14% to 2085669.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 6643648.0, a 0.61% decrease, with the full-year FY2025 number at 3605374.0, up 70.73% from a year prior.
  • Income from Continuing Operations hit 2085669.0 in Q1 2026 for Neuroone Medical Technologies, down from 1437890.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1785322.0 in Q4 2024 to a low of 3522828.0 in Q1 2023.
  • Median Income from Continuing Operations over the past 5 years was 2759727.0 (2022), compared with a mean of 2264627.76.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 153.37% in 2024 and later tumbled 180.54% in 2025.
  • Neuroone Medical Technologies' Income from Continuing Operations stood at 1732769.0 in 2022, then tumbled by 93.04% to 3344900.0 in 2023, then skyrocketed by 153.37% to 1785322.0 in 2024, then tumbled by 180.54% to 1437890.0 in 2025, then crashed by 45.05% to 2085669.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 2085669.0 (Q1 2026), 1437890.0 (Q4 2025), and 1619221.0 (Q3 2025) per Business Quant data.